Winning Health Technology Group Co., Ltd. (SHE:300253)
11.06
-0.34 (-2.98%)
At close: Feb 13, 2026
SHE:300253 Market Cap
SHE:300253 has a market cap or net worth of 24.35 billion as of February 13, 2026. Its market cap has increased by 72.34% in one year.
Market Cap
24.35B
Enterprise Value
24.22B
Revenue
2.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
11.06
Market Cap Chart
Since August 18, 2011, SHE:300253's market cap has increased from 2.30B to 24.35B, an increase of 959.04%. That is a compound annual growth rate of 17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 24.35B | 25.45% |
| Dec 31, 2025 | 19.41B | 24.79% |
| Dec 31, 2024 | 15.55B | 1.39% |
| Dec 29, 2023 | 15.34B | -30.06% |
| Dec 30, 2022 | 21.93B | -39.02% |
| Dec 31, 2021 | 35.97B | -3.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 389.95B |
| WuXi AppTec | 305.99B |
| Shenzhen Mindray Bio-Medical Electronics | 224.67B |
| Sichuan Biokin Pharmaceutical | 119.49B |
| iRay Group | 25.45B |
| Hubei Jumpcan Pharmaceutical | 25.12B |
| Dizal (Jiangsu) Pharmaceutical | 25.02B |
| Joinn Laboratories(China)Co.,Ltd. | 24.64B |